Biểu đồ giá cổ phiếu ARGX
ARGX Tài chính
argenx SE
$851.29
-0.65%
$-5.65
Khi đóng cửa: Aug 14, 16:00:00 GMT-4
$914.91
7.47%
$63.62
Phiên trước giờ: Aug 17, 05:47:27 GMT-4
Quay lại
argenx SE (ARGX) Tài chính
Thống kê chính
Giá đóng cửa trước
$856.94
Giá mở cửa
$844.28
Phạm vi ngày
$837.42 - $914.91
Phạm vi 52 tuần
$650.01 - $953.58
Khối lượng
278.7K
Khối lượng trung bình
327.0K
Tỷ suất cổ tức
--
EPS (TTM)
22.47
Vốn hóa thị trường
$56.8B
argenx SE là gì?
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. The company is headquartered in Amsterdam, Noord-Holland. The company went IPO on 2014-07-10. The company is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The firm develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. The company includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.
